-
Cellectis S.A (NASDAQ:CLLS) announces the potential resale of up to 44M shares or American Depositary Shares of Cellectis S.A. by AstraZeneca Holdings B.V. or its transferees.
-
The shares include: 16M ordinary shares/ADSs, 10M ordinary shares/ADSs issuable upon conversion of Class A Preferred